id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-E-0261-0008,FDA,FDA-2008-E-0261,U.S. Patent and Trademark Office to Nixon Peabody LLP - Notice of Final Determination,Other,LET-Letter,2010-12-28T05:00:00Z,2010,12,2010-12-28T05:00:00Z,,2013-07-27T23:40:43Z,,0,0,0900006480bc0e70
FDA-2008-E-0261-0006,FDA,FDA-2008-E-0261,FDA/CDER to US Patent and Trademark Office - Letter,Other,LET-Letter,2010-03-04T05:00:00Z,2010,3,2010-03-04T05:00:00Z,,2013-07-27T23:10:37Z,,0,0,0900006480ab3b6f
FDA-2008-E-0261-0007,FDA,FDA-2008-E-0261,Determination of Regulatory Review Period for Purposes of Patent Extension; RECOTHROM - Notice,Notice,N-Notice,2010-03-04T05:00:00Z,2010,3,2010-03-04T05:00:00Z,2009-10-06T03:59:59Z,2010-03-04T19:08:15Z,,0,0,0900006480a00ae5